X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (268) 268
female (253) 253
index medicus (214) 214
oncology (162) 162
middle aged (157) 157
ovarian cancer (155) 155
aged (134) 134
adult (124) 124
ovarian neoplasms - genetics (104) 104
cancer (99) 99
ovarian neoplasms - pathology (90) 90
prognosis (87) 87
risk factors (87) 87
case-control studies (73) 73
genetic predisposition to disease (70) 70
polymorphism, single nucleotide (70) 70
risk (70) 70
survival (67) 67
research (62) 62
article (61) 61
carcinoma (61) 61
aged, 80 and over (60) 60
genotype (58) 58
carcinoma, ovarian epithelial (48) 48
genetic aspects (48) 48
obstetrics & gynecology (46) 46
tumors (44) 44
expression (43) 43
breast-cancer (42) 42
neoplasm staging (42) 42
pathology (42) 42
male (39) 39
ovarian neoplasms (39) 39
ovarian neoplasms - epidemiology (39) 39
ovarian neoplasms - mortality (39) 39
immunohistochemistry (38) 38
neoplasms, glandular and epithelial - genetics (36) 36
genome-wide association (35) 35
oncology, experimental (35) 35
public, environmental & occupational health (35) 35
analysis (34) 34
genome-wide association study (33) 33
health aspects (33) 33
mutation (32) 32
ovarian neoplasms - blood (32) 32
biomarkers (31) 31
endocrine system diseases (31) 31
epidemiology (30) 30
metaanalysis (30) 30
care and treatment (29) 29
genes (29) 29
immunology (29) 29
identification (28) 28
chemotherapy (27) 27
denmark (27) 27
gene expression (27) 27
ovarian carcinoma (27) 27
ovarian neoplasms - metabolism (27) 27
young adult (27) 27
ca-125 antigen - blood (26) 26
genetics (26) 26
ovarian neoplasms - diagnosis (26) 26
survival analysis (26) 26
breast cancer (25) 25
female genital diseases and pregnancy complications (25) 25
proteins (25) 25
women (25) 25
association (24) 24
gene expression regulation, neoplastic (24) 24
biomarkers, tumor - blood (23) 23
biomarkers, tumor - genetics (23) 23
genetics & heredity (23) 23
odds ratio (23) 23
prospective studies (23) 23
research article (23) 23
inflammation (22) 22
logistic models (22) 22
medical research (22) 22
microbiology (22) 22
neoplasms, glandular and epithelial - pathology (22) 22
adolescent (21) 21
hematology, oncology and palliative medicine (21) 21
medicine (21) 21
studies (21) 21
variants (21) 21
alleles (20) 20
cancer patients (20) 20
diagnosis (20) 20
mutations (20) 20
ovarian neoplasms - surgery (20) 20
denmark - epidemiology (19) 19
medicin och hälsovetenskap (19) 19
ovarian neoplasms - etiology (19) 19
patients (19) 19
proportional hazards models (19) 19
susceptibility (19) 19
ca125 (18) 18
medical and health sciences (18) 18
multidisciplinary sciences (18) 18
breast (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Sieh, Weiva, PhD and Köbel, Martin, Dr and Longacre, Teri A, Prof and Bowtell, David D, Prof and deFazio, Anna, PhD and Goodman, Marc T, PhD and Høgdall, Estrid, PhD and Deen, Suha, Prof and Wentzensen, Nicolas, MD and Moysich, Kirsten B, Prof and Brenton, James D, MD and Clarke, Blaise A, MD and Menon, Usha, Prof and Gilks, C Blake, Prof and Kim, Andre, MPH and Madore, Jason, MS and Fereday, Sian, BSc and George, Joshy, MEng and Galletta, Laura, BSc and Lurie, Galina, MD and Wilkens, Lynne R, DrPH and Carney, Michael E, MD and Thompson, Pamela J, MPH and Matsuno, Rayna K, PhD and Kjær, Susanne Krüger, Prof and Jensen, Allan, PhD and Høgdall, Claus, Prof and Kalli, Kimberly R, PhD and Fridley, Brooke L, PhD and Keeney, Gary L, MD and Vierkant, Robert A, MS and Cunningham, Julie M, PhD and Brinton, Louise A, PhD and Yang, Hannah P, PhD and Sherman, Mark E, MD and García-Closas, Montserrat, Prof and Lissowska, Jolanta, PhD and Odunsi, Kunle, Prof and Morrison, Carl, MD and Lele, Shashikant, Prof and Bshara, Wiam, MD and Sucheston, Lara, PhD and Jimenez-Linan, Mercedes, MD and Driver, Kristy, BSc and Alsop, Jennifer, BA and Mack, Marie and McGuire, Valerie, PhD and Rothstein, Joseph H, MS and Rosen, Barry P, Prof and Bernardini, Marcus Q, MD and Mackay, Helen, MD and Oza, Amit, Prof and Wozniak, Eva L, BSc and Benjamin, Elizabeth, MD and Gentry-Maharaj, Aleksandra, PhD and Gayther, Simon A, Prof and Tinker, Anna V, MD and Prentice, Leah M, PhD and Chow, Christine, BMLSc and Anglesio, Michael S, PhD and Johnatty, Sharon E, PhD and Chenevix-Trench, Georgia, Prof and Whittemore, Alice S, Prof and Pharoah, Paul DP, Prof and Goode, Ellen L, PhD and Huntsman, David G, Prof and Ramus, Susan J, PhD
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 853 - 862
Journal Article
APMIS, ISSN 0903-4641, 05/2016, Volume 124, Issue 5, pp. 337 - 355
Ovarian cancer (OC) is the most lethal gynecological malignancy in the Western world, and has a very poor prognosis, often due to late diagnosis and emergence... 
ovarian cancer | biomarkers | MicroRNA | Biomarkers | Ovarian cancer | Female | Prognosis | Biomarkers, Tumor - analysis | MicroRNAs - analysis | Ovarian Neoplasms - diagnosis | Humans | Deregulation | Chemotherapy | Analysis | Genetic transcription | Biological markers | Cancer | Gene expression | Medical prognosis | MicroRNAs
Journal Article
PLOS ONE, ISSN 1932-6203, 11/2019, Volume 14, Issue 11, p. e0225249
Ovarian cancer is the fifth most common cancer in women worldwide. Moreover, there are no reliable minimal invasive tests to secure the diagnosis of malignant... 
Care and treatment | Cancer patients | MicroRNA | Ovarian cancer | Plasma | Ovarian carcinoma | Invasiveness | Gynecology | MiRNA | Benign | Breast cancer | Gene expression | Ribonucleic acid--RNA | Studies | Pathology | Hospitals | Surgery | MicroRNAs | Biomarkers | Diagnostic systems | Supervision | Cancer | RNA | Ribonucleic acid | miRNA
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e109430
Purpose: We tested the hypothesis that expression of microRNAs (miRNAs) in cancer tissue can predict effectiveness of bevacizumab added to capecitabine and... 
SURVIVAL | BIOMARKERS | LEUCOVORIN | MULTIDISCIPLINARY SCIENCES | REPORTING RECOMMENDATIONS | NEUROLIGINS | 1ST-LINE THERAPY | COMBINATION | FLUOROURACIL | EXPRESSION | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Fluorouracil - analogs & derivatives | Capecitabine | Tissue Array Analysis | Colorectal Neoplasms - genetics | Deoxycytidine - administration & dosage | Humans | Middle Aged | Male | MicroRNAs - biosynthesis | Treatment Outcome | Bevacizumab | Disease-Free Survival | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Aged | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Antimitotic agents | Cancer patients | Care and treatment | Chemotherapy | MicroRNA | Patient outcomes | Colorectal cancer | Development and progression | Metastasis | Antineoplastic agents | Cancer | Colorectal carcinoma | MiRNA | Clinical trials | Oncology | Gene expression | Patients | Metastases | Polymerase chain reaction | Studies | Pathology | Screening | Oxaliplatin | Experimental design | Correlation analysis | Stromal cells | MicroRNAs | Medical prognosis | Biomarkers | Vascular endothelial growth factor
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 4, pp. 385 - 394
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 11/2014, Volume 23, Issue 11, pp. 2285 - 2295
Journal Article
by Bojesen, Stig E and Pooley, Karen A and Johnatty, Sharon E and Beesley, Jonathan and Michailidou, Kyriaki and Tyrer, Jonathan P and Edwards, Stacey L and Pickett, Hilda A and Shen, Howard C and Smart, Chanel E and Hillman, Kristine M and Mai, Phuong L and Lawrenson, Kate and Stutz, Michael D and Lu, Yi and Karevan, Rod and Woods, Nicholas and Johnston, Rebecca L and French, Juliet D and Chen, Xiaoqing and Weischer, Maren and Nielsen, Sune F and Maranian, Melanie J and Ghoussaini, Maya and Ahmed, Shahana and Baynes, Caroline and Bolla, Manjeet K and Wang, Qin and Dennis, Joe and McGuffog, Lesley and Barrowdale, Daniel and Lee, Anew and Healey, Sue and Lush, Michael and Tessier, Daniel C and Vincent, Daniel and Bacot, Françis and Vergote, Ignace and Lambrechts, Sanina and Despierre, Evelyn and Risch, Harvey A and González-Neira, Anna and Rossing, Mary Anne and Pita, Guillermo and Doherty, Jennifer A and Alvarez, Nuria and Larson, Melissa C and Fridley, Brooke L and Schoof, Nils and Chang-Claude, Jenny and Cicek, Mine S and Peto, Julian and Kalli, Kimberly R and Broeks, Annegien and Armasu, Sebastian M and Schmidt, Marjanka K and Braaf, Linde M and Winterhoff, Boris and Nevanlinna, Heli and Konecny, Gottfried E and Lambrechts, Diether and Rogmann, Lisa and Guénel, Pascal and Teoman, Attila and Milne, Roger L and Garcia, Joaquin J and Cox, Angela and Shridhar, Vijayalakshmi and Burwinkel, Barbara and Marme, Frederik and Hein, Rebecca and Sawyer, Elinor J and Haiman, Christopher A and Wang-Gohrke, Shan and Anulis, Irene L and Moysich, Kirsten B and Hopper, John L and Odunsi, Kunle and Lindblom, Annika and Giles, Graham G and Brenner, Hermann and Simard, Jacques and Lurie, Galina and Fasching, Peter A and Carney, Michael E and Radice, Paolo and Wilkens, Lynne R and Swerdlow, Anthony and Goodman, Marc T and Brauch, Hiltrud and Garcia-Closas, Montserrat and Hillemanns, Peter and Winqvist, Robert and Dürst, Matthias and Devilee, Peter and Runnebaum, Ingo and Jakubowska, Anna and Lubinski, Jan and Mannermaa, Arto and Butzow, Ralf and ... and Gene Environm Interactimi Breast and Kathleen Cuningham Fdn Consortium and Australian Ovarian Canc Study and Epidemiological Study BRCA1 and Hereditary Breast Ovarian Canc Res and Genetic Modifiers Canc Risk BRCA1 and Australian Canc Study and Swedish Breast Canc Study SWE-BRCA and The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) and Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) and Gene Environment Interaction and Breast Cancer (GENICA) and Swedish Breast Cancer Study (SWE-BRCA) and Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE) and Australian Ovarian Cancer Study and Australian Cancer Study and Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) and Medicinska fakulteten and Umeå universitet and Institutionen för strålningsvetenskaper
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 371 - 384
Journal Article
International Journal of Oncology, ISSN 1019-6439, 01/2018, Volume 52, Issue 1, pp. 5 - 18
Annexin A2 is a 36-kDa protein interfering with multiple cellular processes especially in cancer progression. The present review aimed to show the relations... 
S100 | Methodologies | Tumour markers | Annexin A2 | Tissue expression | Cancer | METASTASIS | ANGIOGENESIS | methodologies | DOWN-REGULATION | CELL-PROLIFERATION | BREAST-CANCER | COLON-CANCER | INVASION | PLASMINOGEN-ACTIVATOR | ONCOLOGY | II EXPRESSION | cancer | tumour markers | tissue expression | EPIDIDYMIS PROTEIN 4
Journal Article